Free shipping on all orders over $ 500

Afuresertib hydrochloride

Cat. No. M9024

All AbMole products are for research use only, cannot be used for human consumption.

Afuresertib hydrochloride Structure
Synonym:

GSK2110183B; LAE002 HCl

Size Price Availability Quantity
2mg USD 65  USD65 In stock
5mg USD 90  USD90 In stock
10mg USD 150  USD150 In stock
50mg USD 470  USD470 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively. Afuresertib HCl binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Afuresertib significantly increases caspase-3 and caspase-7 activities and apoptotic cell number among ACC-MESO-4 and MSTO-211H cells. Afuresertib strongly arrests the cell cycle in the G1 phase. Afuresertib significantly enhances cisplatin-induced cytotoxicity. Afuresertib modulates the expression E2F1 and MYC, which are associated with fibroblast core serum response.

Protocol (for reference only)
Cell Experiment
Cell lines MPM cells
Preparation method MPM cells are seeded in 96-well plates (cell density, 2.5×103 cells/well) and are incubated for 24 h at 37°C. Next, the cells are incubated in a medium containing indicated concentrations of Akt inhibitors (e.g., Afuresertib ; 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, and 0.01 μM) for 72 h. Next, MTT solution is added to each well, and the cells are incubated for 4 h. Finally, the cells are incubated overnight with lysis buffer (10% SDS in 0.01 mol/L hydrogen chloride). Absorbance is measured at 550 nm using SpectraMAX M5 spectrophotometer.
Concentrations 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, and 0.01 μM
Incubation time 72 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 463.78
Formula C18H18Cl3FN4OS
CAS Number 1047645-82-8
Solubility (25°C) DMSO 90 mg/mL
Storage -20°C, protect from light, sealed
References

[1] Yamaji M, et al. Cancer Med. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.

[2] Spencer A, et al. Blood. The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma.

Related Akt Products
(E)-Akt inhibitor-IV

(E)-Akt inhibitor-IV is a PI3K-Akt inhibitor, with potent cytotoxic.

K-80003

K-80003 is a potent inhibitor of tRXRα-dependent Akt activation and cancer cell growth.

FPA-124 

FPA-124, a cell-permeable copper complex, is a selective Akt inhibitor with an IC50 of 0.1 μM.

SPOP-IN-1 

SPOP-IN-1 is a selective SPOP E3 ubiquitin ligase inhibitor.

10-DEBC hydrochloride 

10-DEBC hydrochloride is a selective Akt inhibitor, with an IC50 of 1.28 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Afuresertib hydrochloride, GSK2110183B; LAE002 HCl supplier, Akt, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.